Kayak Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-29.
Kayak Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 29, 2025. The filing reports $6.63M sold. Its industry group is Biotechnology. It names Tyler Brous (Director), Conor Richardson (Executive Officer), Hornblower Josiah (Executive Officer, Director) (SEC Form D, September 29, 2025).
Is this your company?
Sell to companies like Kayak Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Kayak Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Kayak Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Texas, filed in September 2025, largest first.
Get an email when Kayak Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Kayak Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Kayak Therapeutics, Inc. →Get the full cited report on Kayak Therapeutics, Inc.
What the filing shows about Kayak Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Kayak Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Kayak Therapeutics, Inc.'s address as 3317 Bowman Avenue, Austin, TX 78703.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Kayak Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Kayak Therapeutics, Inc. See pricing
Kayak Therapeutics, Inc. is a registered filer with the SEC (CIK 2088831) and has filed since 2025-09-29. 3 filings are on record, the latest on 2026-08-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Kayak Therapeutics, Inc.'s Form D of 2025-09-29 names Tyler Brous, Conor Richardson and Hornblower Josiah as its officers, directors or promoters.
Its new offerings report $18.57M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Kayak Therapeutics is harnessing the power of proven clinical pathways to develop and deliver innovative therapies that treat patients with cancer.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Tyler Brous is named as Director on the Form D that Kayak Therapeutics, Inc. filed with the SEC on 29 September 2025, one of 3 people that filing names.
Conor Richardson is named as Executive Officer on the Form D that Kayak Therapeutics, Inc. filed with the SEC on 29 September 2025, one of 3 people that filing names.
Hornblower Josiah is named as Executive Officer and Director on the Form D that Kayak Therapeutics, Inc. filed with the SEC on 29 September 2025, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2025-09-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Kayak Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Kayak Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Kayak Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Kayak Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Kayak Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (kayaktherapeutics.com).
Each opens in a new tab, filled in for Kayak Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Austin
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/kayak-therapeutics-inc-form-d-25000001